PathAI’s AIM-MASH AI Assist Receives FDA Qualification for MASH Clinical Trials
The AI-powered pathology tool becomes the first AI-based drug development tool to receive FDA qualification, following earlier EMA approval.
Read More
Search Results for: liver disease
Valar Labs Partners with PathNet Lab to Expand AI Bladder Cancer Diagnostics
The collaboration will provide urologists and oncologists nationwide access to AI-powered tools for non-muscle invasive bladder cancer management.
Read More
BD Expands BD Max System Menu with IVDR-Certified Viasure Assays
Partnership with Certest Biotec adds respiratory and STI molecular diagnostic panels for European laboratories.
Read More
Why Cervical Cancer Screening Rates Are Falling—and What Could Help Reverse the Trend
Despite effective prevention tools, Millennials are delaying screening. New approaches may help remove barriers to participation.
Read More
Yenos Analytical Launches Multi-Cancer Early Detection Urine Test
The direct-to-consumer laboratory-developed test detects six cancer types with 97% sensitivity and specificity using microRNA biomarkers, according to the company.
Read More